Bayer in Berkeley — Looking Ahead
Highly targeted therapies, such as cell and gene therapies, are poised to revolutionize medicine, making it possible to move from treatment toward a cure in several diseases. But these novel therapies are very complex and difficult to manufacture. That’s why Bayer is working to transform its U.S. biopharma development and manufacturing site in Berkeley, California, to be on the cutting-edge of specialty medicine innovation.
In addition to its in-house expertise, Bayer has created many channels for what it calls “Collaborating for a Cure,” developing a wide range of strategic partnerships in the Bay Area and beyond.
